Cancer signaling networks play key roles in cancer pathogenesis and drug discovery. The RAS/RAF/MAPK pathway has a crucial role in cell biology and cancer progression, with Raf-1 proto-oncogene, serine/threonine kinase (RAF1) serving as a key regulatory protein in this pathway. This study presents a comprehensive analysis of site-specific phosphorylation of RAF1 and its potential implications in cancer development and therapeutics. Through comprehensive analysis of human cellular phosphoproteomic datasets (769 qualitatively profiled and 196 quantitatively differentially expressed), we identified 63 phosphorylation sites on RAF1. Among these, 29 sites demonstrated distinct regulatory effects in various contexts, including cancer, infections, and signaling-related studies. Notably, our analysis revealed that the most prevalent phosphorylation sites, S259, S621, S642, S296, S301, and S43 primarily regulate kinase-independent RAF1 signaling. This observation suggests a complex interplay between phosphorylation events and RAF1 function, beyond its canonical kinase activity. By elucidating these regulatory mechanisms, our study provides valuable insights into the intricate regulation of RAF1 and its potential impact on cancer-related signaling pathways. These findings not only advance the current understanding of RAF1 regulation but also open new possibilities for the development of targeted therapeutic interventions for cancer treatment. Further investigation of these phosphorylation sites and their functional consequences may lead to novel strategies for cancer treatment innovation by modulating RAF1 activity in cancer cells.
Dcunha et al. (Wed,) studied this question.